Mccoy Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.45 Cr
as on 11-12-2024
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.75 Cr
as on 11-12-2024
- Satisfied Charges ₹ 1.60 Cr
as on 11-12-2024
- Revenue 1.96%
(FY 2022)
- Profit 11361.79%
(FY 2022)
- Ebitda 52.80%
(FY 2022)
- Net Worth 25.91%
(FY 2022)
- Total Assets 5.59%
(FY 2022)
About Mccoy Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.45 Cr.
The company currently has active open charges totaling ₹40.75 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Siddharth Panikar, Ashok Nair, and Arjun Panikar serve as directors at the Company.
- CIN/LLPIN
U30007MH1994PTC079810
- Company No.
079810
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mccoy Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Panikar  | Director | 01-Jan-2004 | Current |
| Siddharth Panikar | Director | 16-Mar-2002 | Current |
| Ashok Nair | Director | 17-Jun-2000 | Current |
Financial Performance and Corporate Structure Insights of Mccoy Pharma.
Mccoy Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.96% increase. The company also saw a substantial improvement in profitability, with a 11361.79% increase in profit. The company's net worth Soared by an impressive increase of 25.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mccoy Pharma?
In 2022, Mccoy Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vaks Pharma Private LimitedActive 23 years 1 monthSiddharth Panikar and Arjun Panikar are mutual person
Mitoch Pharma Private LimitedActive 32 years 2 monthsSiddharth Panikar and Arjun Panikar are mutual person
P. N. Packaging Private LimitedActive 7 years 1 monthSiddharth Panikar and Ashok Nair are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 07 Sep 2023 | ₹2.00 M | Open |
Axis Bank Limited Creation Date: 25 May 2023 | ₹1.20 Cr | Open |
Axis Bank Limited Creation Date: 19 Sep 2020 | ₹3.00 Cr | Open |
How Many Employees Work at Mccoy Pharma?
Mccoy Pharma has a workforce of 94 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mccoy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mccoy Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
